Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Who should get flu, COVID and RSV vaccines—and when?
According to the CDC, RSV is the leading cause of infant hospitalization in the U.S.
New office will take over the duties of the current White House COVID-19 and mpox response teams.
Adults ages 60 and older should discuss the new vaccines with their health care providers.
Arexvy RSV vaccine is now approved for individuals age 60 and older.
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should long COVID surprise us?
The number of pediatric inpatient units in hospitals fell 19% from 2008 to 2018.
These three respiratory illnesses—and others—share many of the same symptoms.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
Vermont serves as a window into what’s possible as the U.S. learns to live with COVID-19.
What protects most children from becoming seriously ill? And why does that protection sometimes fail?
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.